
The one-day conference will feature national, regional and local experts addressing the recent FDA approval of Adakveo and Oxbryta in the treatment of sickle disease and advances in gene therapy. A highlight of the conference will be to engage a sickle cell patient who has undergone gene therapy.
To register for the conference, visit cmetracker.net. For more information, email vgardner@health.southalabama.edu or call (251) 470-5893.